Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 13Terminated 4Unknown 2Active not recruiting 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 77Thoracic 44Other hematologic neoplasm 34CNS 17Gynecologic 9Myeloid 8Other solid neoplasm 7Genitourinary 7Breast 6Sarcoma 4Plasma cell 4Gastrointestinal 3NET 2Endocrine 2Dermatologic 2Classical hematology 2Tumor-Agnostic 1

Conditions

Myelodysplastic Syndromes 2Leukemia 2Anemia, Refractory, with Excess of Blasts 2Leukemia, Myelomonocytic, Chronic 1Anemia, Refractory 1

Interventions

avatrombopag 4iron isomaltoside 1000 3hetrombopag 3ferric carboxymaltose 3Cytarabine 3eltrombopag 2Rivaroxaban 2Radiotherapy 2Meropenem 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Erythropoietin 2Cyclophosphamide 2thymoglobulin 1stinging nettle lectin 1romiplostim 1raltitrexed 1peppermint oil 1pegfilgrastim 1oprelvekin 1fludarabine phosphate 1fludarabine 1ferrous succinate 1ferrous fumarate 1ferric derisomaltose 1epoetin beta 1Vitamin B 12 1Vancomycin 1Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Etoposide × Classical hematology × Clear all
NCT00003602 2013-09-20

Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
400 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

NCT00002926 2010-05-27

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡